222 related articles for article (PubMed ID: 23169631)
1. Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor.
Kirkpatrick A; Heo J; Abrol R; Goddard WA
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):19988-93. PubMed ID: 23169631
[TBL] [Abstract][Full Text] [Related]
2. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
Runge S; Thøgersen H; Madsen K; Lau J; Rudolph R
J Biol Chem; 2008 Apr; 283(17):11340-7. PubMed ID: 18287102
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular domain.
West GM; Willard FS; Sloop KW; Showalter AD; Pascal BD; Griffin PR
PLoS One; 2014; 9(9):e105683. PubMed ID: 25180755
[TBL] [Abstract][Full Text] [Related]
5. Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors.
Yin Y; de Waal PW; He Y; Zhao LH; Yang D; Cai X; Jiang Y; Melcher K; Wang MW; Xu HE
J Biol Chem; 2017 Jun; 292(24):9865-9881. PubMed ID: 28356352
[TBL] [Abstract][Full Text] [Related]
6. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.
Underwood CR; Garibay P; Knudsen LB; Hastrup S; Peters GH; Rudolph R; Reedtz-Runge S
J Biol Chem; 2010 Jan; 285(1):723-30. PubMed ID: 19861722
[TBL] [Abstract][Full Text] [Related]
8. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.
López de Maturana R; Willshaw A; Kuntzsch A; Rudolph R; Donnelly D
J Biol Chem; 2003 Mar; 278(12):10195-200. PubMed ID: 12524435
[TBL] [Abstract][Full Text] [Related]
9. Purification of family B G protein-coupled receptors using nanodiscs: Application to human glucagon-like peptide-1 receptor.
Cai Y; Liu Y; Culhane KJ; DeVree BT; Yang Y; Sunahara RK; Yan ECY
PLoS One; 2017; 12(6):e0179568. PubMed ID: 28609478
[TBL] [Abstract][Full Text] [Related]
10. Structure of the glucagon receptor in complex with a glucagon analogue.
Zhang H; Qiao A; Yang L; Van Eps N; Frederiksen KS; Yang D; Dai A; Cai X; Zhang H; Yi C; Cao C; He L; Yang H; Lau J; Ernst OP; Hanson MA; Stevens RC; Wang MW; Reedtz-Runge S; Jiang H; Zhao Q; Wu B
Nature; 2018 Jan; 553(7686):106-110. PubMed ID: 29300013
[TBL] [Abstract][Full Text] [Related]
11. Ligand binding pocket formed by evolutionarily conserved residues in the glucagon-like peptide-1 (GLP-1) receptor core domain.
Moon MJ; Lee YN; Park S; Reyes-Alcaraz A; Hwang JI; Millar RP; Choe H; Seong JY
J Biol Chem; 2015 Feb; 290(9):5696-706. PubMed ID: 25561730
[TBL] [Abstract][Full Text] [Related]
12. Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism.
Lei S; Clydesdale L; Dai A; Cai X; Feng Y; Yang D; Liang YL; Koole C; Zhao P; Coudrat T; Christopoulos A; Wang MW; Wootten D; Sexton PM
J Biol Chem; 2018 Jun; 293(24):9370-9387. PubMed ID: 29717000
[TBL] [Abstract][Full Text] [Related]
13. Site of action of a pentapeptide agonist at the glucagon-like peptide-1 receptor. Insight into a small molecule agonist-binding pocket.
Dong M; Pinon DI; Miller LJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):638-41. PubMed ID: 22079758
[TBL] [Abstract][Full Text] [Related]
14. A free-energy landscape for the glucagon-like peptide 1 receptor GLP1R.
Alhadeff R; Warshel A
Proteins; 2020 Jan; 88(1):127-134. PubMed ID: 31294890
[TBL] [Abstract][Full Text] [Related]
15. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
Al-Sabah S; Donnelly D
Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
[TBL] [Abstract][Full Text] [Related]
16. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
[TBL] [Abstract][Full Text] [Related]
17. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor.
Montrose-Rafizadeh C; Yang H; Rodgers BD; Beday A; Pritchette LA; Eng J
J Biol Chem; 1997 Aug; 272(34):21201-6. PubMed ID: 9261127
[TBL] [Abstract][Full Text] [Related]
18. Fluorescent exendin-4 derivatives for pancreatic β-cell analysis.
Clardy SM; Keliher EJ; Mohan JF; Sebas M; Benoist C; Mathis D; Weissleder R
Bioconjug Chem; 2014 Jan; 25(1):171-7. PubMed ID: 24328216
[TBL] [Abstract][Full Text] [Related]
19. Evolutionarily conserved residues at glucagon-like peptide-1 (GLP-1) receptor core confer ligand-induced receptor activation.
Moon MJ; Kim HY; Park S; Kim DK; Cho EB; Park CR; You DJ; Hwang JI; Kim K; Choe H; Seong JY
J Biol Chem; 2012 Feb; 287(6):3873-84. PubMed ID: 22105074
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.
Pocai A; Carrington PE; Adams JR; Wright M; Eiermann G; Zhu L; Du X; Petrov A; Lassman ME; Jiang G; Liu F; Miller C; Tota LM; Zhou G; Zhang X; Sountis MM; Santoprete A; Capito' E; Chicchi GG; Thornberry N; Bianchi E; Pessi A; Marsh DJ; SinhaRoy R
Diabetes; 2009 Oct; 58(10):2258-66. PubMed ID: 19602537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
